6months of 0.5 fin 1.5min should I bump up the dose? Finasteride/Dutasteride 5/12/2025
The conversation is about hair loss treatment using finasteride and minoxidil, with the original poster considering adjusting their dosage after experiencing side effects. Other users suggest trying different dosages or adding dutasteride, emphasizing consistency and consulting a specialist if side effects occur.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity 4 years of fin+min, 6 months of dut+min progress
The user has been using finasteride and minoxidil for 4 years and switched to dutasteride and minoxidil 6 months ago, but is concerned about lack of progress and hair loss. They have not experienced side effects and are considering other options like blood tests and dosage adjustments.
community Seeking Experiences with 1-2x Weekly Dutasteride Dose Adjustments
The user is considering adjusting their hair loss treatment by adding 1-2 weekly doses of Dutasteride to their current daily regimen of Minoxidil and Finasteride, aiming to gradually increase effectiveness while minimizing drug use. They seek experiences from others who have tried similar combination therapies.
community 7 month hairline recovery (jul - feb)
A user shared their 7-month hairline recovery using 1 mg finasteride and 5 mg minoxidil daily. They experienced significant hair growth, including unwanted facial hair, and discussed potential side effects and dosage adjustments with others.
community Dutasteride power compared to finasteride
Dutasteride is generally considered more effective than finasteride for hair regrowth, with some users experiencing better results, especially at higher doses. However, individual responses vary, and some users report side effects or no response to either treatment.
community What fin did for me. Positive outcome (so far)
A user's positive experience with finasteride for hair loss treatment, and another user's experience with minoxidil. They discuss the potential side effects of finasteride and the success they have had in regrowing baby hairs after several months of use.
community A year on dut 0.5 and min 2.5 mg oral
The conversation discusses hair loss treatments, specifically using Dutasteride and oral Minoxidil. Opinions vary on the effectiveness, with some suggesting dosage adjustments and others debating the presence of hair loss.
Related Research
6 / 6 resultsresearch Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
This review reports that nirmatrelvir-ritonavir has significant drug-drug interactions with many common dermatological medications, whereas molnupiravir may be an alternative therapy due to the absence of such interactions observed so far.
research Medical treatments for male and female pattern hair loss
This review discusses the various treatment options for male and female pattern hair loss and provides no new clinical results; the authors outline the most effective strategies based on existing evidence.
research Updates in Treatment for Androgenetic Alopecia
This review discusses current and emerging treatments for androgenetic alopecia, covering mechanisms, efficacy, and safety of both androgen-targeted and non-androgen-targeted approaches, but reports no new clinical results.
research Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date
This review examines the pharmacology, clinical efficacy, and adverse effects of oral finasteride for female pattern hair loss, and discusses potential new treatments like topical finasteride and dutasteride, but reports no new clinical results.
research 26-SNP Panel Aids Guiding Androgenetic Alopecia Therapy and Provides Insight into Mechanisms of Action
This study found that using a pharmacogenetic panel with 26 SNPs can improve treatment outcomes for androgenetic alopecia, as overall response rates to minoxidil, finasteride, and dutasteride were high, and specific genetic markers predicted poor responses to these drugs.
research Androgenetic alopecia: An update
This study describes androgenetic alopecia as a common non-scarring hair loss condition primarily influenced by genetic factors and androgen sensitivity, notably impacting psychosocial well-being, especially in females and younger males seeking treatment.